# PharmaCyte Biotech, Inc.: Form 8-K, filed Jun 28, 2012

- Company: [PharmaCyte Biotech, Inc.](/companies/pmcb.md) (CIK 1157075)
- Form: 8-K
- Filed: 2012-06-28
- Accepted by EDGAR: Jun 28, 2012, 09:34 ET
- Period: 2011-05-26
- Accession: 0001262463-12-000242
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1157075/000126246312000242/nuvilex8krd20120627.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157075/000126246312000242/

## Items reported

- Item 2.01: Completion of an acquisition or disposition
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157075/000126246312000242/nuvilex8krd20120627.htm

Filed Jun 28, 2012.
Source: SEC EDGAR, the filing index for accession 0001262463-12-000242. Last ingested by Listed: Nov 14, 2026, 20:52 ET. No prices; not investment advice.
